Reduced cost of managing exacerbations with stable dose treatment with salmeterol/fluticasone (SFC) compared with adjustable maintenance dosing (AMD) with formoterol/budesonide (FBC)

BACKGROUND: The high cost of asthma care is largely attributed to poor control of disease, in particular the treatment of exacerbations. METHOD: A 1-year, randomised, double blind, double dummy study in adult asthmatics currently receiving >500–1000mcg ICS or 200–500mcg ICS+LABA daily. Both AMD a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prim Care Respir J
Autori principali: Pieters, Willem R., Williams, Angela E., Follows, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2005
Soggetti:
Abstact
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743588/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcrj.2005.06.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi